4.7 Review

Long Noncoding RNAs in the Regulation of Asthma: Current Research and Clinical Implications

期刊

FRONTIERS IN PHARMACOLOGY
卷 11, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2020.532849

关键词

asthma; long noncoding RNAs; airway inflammation; airway remodeling; glucocorticoid insensitivity

资金

  1. National Natural Science Foundation of China [81774074, 81704154]
  2. Shanghai science and technology commission [17401930300, 18401971300]
  3. Young Elite Scientists Sponsorship Program by China Association for Science and Technology [2018QNRC001]
  4. Shanghai science and technology commission scientific research project [18401901800]

向作者/读者索取更多资源

Asthma is a chronic airway inflammatory disorder related to variable expiratory airflow limitation, leading to wheeze, shortness of breath, chest tightness, and cough. Its characteristic features include airway inflammation, airway remodeling and airway hyperresponsiveness. The pathogenesis of asthma remains extremely complicated and the detailed mechanisms are not clarified. Long noncoding RNAs (lncRNAs) have been reported to play a prominent role in asthma and function as modulators of various aspects in pathological progress of asthma. Here, we summarize recent advances of lncRNAs in asthma pathogenesis to guide future researches, clinical treatment and drug development, including their regulatory functions in the T helper (Th) 1/Th2 imbalance, Th17/T regulatory (Treg) imbalance, eosinophils dysfunction, macrophage polarization, airway smooth muscle cells proliferation, and glucocorticoid insensitivity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据